3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
14
OTHER_GOV
2
INDUSTRY
2
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Postoperative Hemorrhage
1
Postoperative Complications
1
Myofibroma
1
Leiomyoma
1
Blood Loss, Surgical
1
Interventions
Tamoxifen
10
Docetaxel
8
Trastuzumab
7
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Exercise
6
Control Groups
6
exemestane
5
Indocyanine Green
5
Cyclophosphamide
5
Carboplatin
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Vinorelbine
4
Doxorubicin
4
Capecitabine
4
pyrotinib
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Fulvestrant
3
Cisplatin
3
ferumoxides
2
Zoledronic Acid
2
Tablets
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Breast Neoplasms
×
Tablets
×
Clear all
NCT05722795
2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA
Recruiting
40 enrolled
NCT03024580
2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
20 enrolled